Paula T Einhorn

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis
    Paula T Einhorn
    National Heart, Lung, and Blood Institute, Division of Epidemiology and Clinical Applications, Bethesda, MD 20892 7936, USA
    Am Heart J 153:42-53. 2007
  2. ncbi request reprint ALLHAT: still providing correct answers after 7 years
    Paula T Einhorn
    National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA
    Curr Opin Cardiol 25:355-65. 2010
  3. ncbi request reprint Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT
    Efrain Reisin
    aSection of Nephrology and Hypertension, Louisiana State University Health Science Center, New Orleans, Louisiana bDivision of Nephrology Hypertension, Mayo Clinic, Rochester, Minnesota cCoordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston, Texas dDivision of Endocrinology, Kaiser Permanente of Georgia and Emory University School of Medicine, Atlanta, Georgia eThe National Heart, Lung, and Blood Institute, Bethesda, Maryland fCenter for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, Wisconsin gHoward University Hypertension and Lipid Clinic, Howard University Hospital, Washington, District of Columbia hVeterans Affairs Medical Center and Wright State University Veterans Affairs Campus, Dayton, Ohio, USA
    J Hypertens 32:1503-13. 2014
  4. ncbi request reprint Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Karen L Margolis
    HealthPartners Research Foundation PO Box 1524, Mailstop 21111R, Minneapolis, MN 55440 1524, USA
    Hypertension 50:854-61. 2007
  5. pmc Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Jackson T Wright
    Department of Medicine, General Clinical Research Center, Cleveland, Ohio, USA
    Arch Intern Med 168:207-17. 2008
  6. ncbi request reprint Action on racial disparity in hypertension control
    Paula T Einhorn
    Arch Intern Med 166:812. 2006
  7. doi request reprint Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute
    Barry L Carter
    Division of Clinical and Administrative Pharmacy, Rm 527, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA
    Hypertension 52:30-6. 2008

Detail Information

Publications7

  1. ncbi request reprint The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis
    Paula T Einhorn
    National Heart, Lung, and Blood Institute, Division of Epidemiology and Clinical Applications, Bethesda, MD 20892 7936, USA
    Am Heart J 153:42-53. 2007
    ..However, questions have been raised regarding the validity of the HF diagnosis...
  2. ncbi request reprint ALLHAT: still providing correct answers after 7 years
    Paula T Einhorn
    National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA
    Curr Opin Cardiol 25:355-65. 2010
    ....
  3. ncbi request reprint Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT
    Efrain Reisin
    aSection of Nephrology and Hypertension, Louisiana State University Health Science Center, New Orleans, Louisiana bDivision of Nephrology Hypertension, Mayo Clinic, Rochester, Minnesota cCoordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston, Texas dDivision of Endocrinology, Kaiser Permanente of Georgia and Emory University School of Medicine, Atlanta, Georgia eThe National Heart, Lung, and Blood Institute, Bethesda, Maryland fCenter for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, Wisconsin gHoward University Hypertension and Lipid Clinic, Howard University Hospital, Washington, District of Columbia hVeterans Affairs Medical Center and Wright State University Veterans Affairs Campus, Dayton, Ohio, USA
    J Hypertens 32:1503-13. 2014
    ..9), and obese (BMI >30)]...
  4. ncbi request reprint Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Karen L Margolis
    HealthPartners Research Foundation PO Box 1524, Mailstop 21111R, Minneapolis, MN 55440 1524, USA
    Hypertension 50:854-61. 2007
    ....
  5. pmc Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Jackson T Wright
    Department of Medicine, General Clinical Research Center, Cleveland, Ohio, USA
    Arch Intern Med 168:207-17. 2008
    ....
  6. ncbi request reprint Action on racial disparity in hypertension control
    Paula T Einhorn
    Arch Intern Med 166:812. 2006
  7. doi request reprint Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute
    Barry L Carter
    Division of Clinical and Administrative Pharmacy, Rm 527, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA
    Hypertension 52:30-6. 2008